Experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk. (August 2021)

• Record Type: Journal Article
• Authors: Lebowitz, Matthew S.; Appelbaum, Paul S.; Dixon, Lisa B.; Girgis, Ragy R.; Wall, Melanie M.
• Is Part Of: Journal of psychiatric research. Volume 140(2021)
• Page Start: 316
• Page End: 322
• Publication Date: 2021-08
• Subjects: Substance use -- Psychosis -- Health psychology -- Behavioral intentions -- Self-efficacy -- Locus of control; Psychiatry -- Periodicals; Mental Disorders -- Periodicals; Maladies mentales -- Périodiques; Psychiatry; Electronic journals; Periodicals; 616.89005
• DOI: 10.1016/j.jpsychires.2021.05.066
• Languages: English
• ISSNs: 0022-3956

Abstract

Abstract: Marijuana use may increase schizophrenia risk, and this effect may be genetically moderated. We investigated how hypothetical genetic test results indicating the presence or absence of heightened schizophrenia risk in reaction to marijuana use would affect attitudes toward marijuana use. In two experiments, participants were randomized to hypothetical scenarios in which genetic testing showed the presence or absence of a predisposition for marijuana use to increase their schizophrenia risk, or to a control condition with no mention of genetic testing. Experiment 1 used a sample of 801 U.S. young adults recruited via Amazon.com's Mechanical Turk platform. Experiment 2 replicated the same procedures with a nationally representative sample of 800 U.S. adults aged 18–30. In Experiment 1, those in the predisposition condition, compared to the control condition, rated the likelihood and importance of their avoiding marijuana as significantly higher, whereas those in the no-predisposition condition rated both as significantly lower. In experiment 2, these findings were largely replicated for the predisposition condition but not the no-predisposition condition, and prior marijuana use was a significant moderator, with the effects of the predisposition condition confined to participants who reported having used marijuana. If these results are predictive of responses to actual genetic testing, they suggest that genetic test results indicating that marijuana use will increase one's schizophrenia risk may incentivize abstinence, especially for those with prior marijuana use. Future research could further investigate whether genetic test results indicating the absence of such a predisposition might disincentivize abstinence from marijuana use.